Publications de l'équipe
Publications de l'équipe

2016

  1. Lebert F, Leroy M, Pasquier F, Strubel D. Young onset demented patients in French cognitive-behavioral specialized units Geriatr Psychol Neuropsychiatr Vieil. 2016 Jun 1;14(2):194-200. doi: 10.1684/pnv.2016.0607.
  2. Zarea A, Charbonnier C, Rovelet-Lecrux A, Nicolas G, Rousseau S, Borden A, Pariente J, Le Ber I, Pasquier F, Formaglio M, Martinaud O, Rollin-Sillaire A, Sarazin M, Croisile B, Boutoleau-Bretonnière C, Ceccaldi M, Gabelle A, Chamard L, Blanc F, Sellal F, Paquet C, Campion D, Hannequin D, Wallon D; PHRC GMAJ Collaborators. Seizures in dominantly inherited Alzheimer disease Neurology. 2016 Aug 30;87(9):912-9.
  3. De Reuck J, Auger F, Durieux N, Deramecourt V, Maurage CA, Lebert F, Leys D, Cordonnier C, Pasquier F, Bordet R.The topography of cortical microbleeds in frontotemporal lobar degeneration: a post-mortem 7.0-tesla magnetic resonance study Folia Neuropathol. 2016;54(2):149-55.
  4. Magnin E, Démonet JF, Wallon D, Dumurgier J, Troussière AC, Jager A, Duron E, Gabelle A, de la Sayette V, Volpe-Gillot L, Tio G, Evain S, Boutoleau-Bretonnière C, Enderle A, Mouton-Liger F, Robert P, Hannequin D, Pasquier F, Hugon J, Paquet C; ePLM collaborators Primary Progressive Aphasia in the Network of French Alzheimer Plan Memory Centers. J Alzheimers Dis. 2016 Sep 2. [Epub ahead of print]
  5. De Reuck J, Deramecourt V, Cordonnier C, Pasquier F, Leys D, Maurage CA, Bordet R. The incidence of post-mortem neurodegenerative and cerebrovascular pathology in mixed dementia. J Neurol Sci. 2016 Jul 15;366:164-6.
  6. Le Guennec K, Nicolas G, Quenez O, Charbonnier C, Wallon D, Bellenguez C, Grenier-Boley B, Rousseau S, Richard AC, Rovelet-Lecrux A, Bacq D, Garnier JG, Olaso R, Boland A, Meyer V, Deleuze JF, Amouyel P, Munter HM, Bourque G, Lathrop M, Frebourg T, Redon R, Letenneur L, Dartigues JF, Pasquier F, Rollin-Sillaire A, Génin E, Lambert JC, Hannequin D, Campion D; CNR-MAJ collaborators. ABCA7 rare variants and Alzheimer disease risk. Neurology. 2016 Jun 7;86(23):2134-7.
  7. Grangeon L, Paquet C, Bombois S, Quillard-Muraine M, Martinaud O, Bourre B, Lefaucheur R, Nicolas G, Dumurgier J, Gerardin E, Jan M, Laplanche JL, Peoc’h K, Hugon J, Pasquier F, Maltête D, Hannequin D, Wallon D; collaborators of the ePLM.fr group. Differential Diagnosis of Dementia with High Levels of Cerebrospinal Fluid Tau Protein. J Alzheimers Dis. 2016;51(3):905-13.
  8. Nicolas G, Charbonnier C, Wallon D, Quenez O, Bellenguez C, Grenier-Boley B, Rousseau S, Richard AC, Rovelet-Lecrux A, Le Guennec K, Bacq D, Garnier JG, Olaso R, Boland A, Meyer V, Deleuze JF, Amouyel P, Munter HM, Bourque G, Lathrop M, Frebourg T, Redon R, Letenneur L, Dartigues JF, Génin E, Lambert JC, Hannequin D, Campion D; CNR-MAJ collaborators. SORL1 rare variants: a major risk factor for familial early-onset Alzheimer’s disease. Mol Psychiatry. 2016 Jun;21(6):831-6.
  9. Nicolas G, Wallon D, Charbonnier C, Quenez O, Rousseau S, Richard AC, Rovelet-Lecrux A, Coutant S, Le Guennec K, Bacq D, Garnier JG, Olaso R, Boland A, Meyer V, Deleuze JF, Munter HM, Bourque G, Auld D, Montpetit A, Lathrop M, Guyant-Maréchal L, Martinaud O, Pariente J, Rollin-Sillaire A, Pasquier F, Le Ber I, Sarazin M, Croisile B, Boutoleau-Bretonnière C, Thomas-Antérion C, Paquet C, Sauvée M, Moreaud O, Gabelle A, Sellal F, Ceccaldi M, Chamard L, Blanc F, Frebourg T, Campion D, Hannequin D. Screening of dementia genes by whole-exome sequencing in early-onset Alzheimer disease: input and lessons. Eur J Hum Genet. 2016 May;24(5):710-6.
  10. Verclytte S, Lopes R, Lenfant P, Rollin A, Semah F, Leclerc X, Pasquier F, Delmaire C. Cerebral Hypoperfusion and Hypometabolism Detected by Arterial Spin Labeling MRI and FDG-PET in Early-Onset Alzheimer’s Disease. J Neuroimaging. 2016 Mar-Apr;26(2):207-12.
  11. Ducharme F, Lachance L, Kergoat MJ, Coulombe R, Antoine P, Pasquier F. A Comparative Descriptive Study of Characteristics of Early- and Late-Onset Dementia Family Caregivers. Am J Alzheimers Dis Other Demen. 2016 Feb;31(1):48-56.
  12. Wawrziczny E, Antoine P, Ducharme F, Kergoat MJ, Pasquier F. Couples’ experiences with early-onset dementia: An interpretative phenomenological analysis of dyadic dynamics. Dementia (London). 2016 Sep;15(5):1082-99

2015

  1. Le Bouc R, Marelli C, Beaufils E, Berr C, Hommet C, Touchon J, Pasquier F, Deramecourt V. Limiting Factors of Brain Donation in Neurodegenerative Diseases: The Example of French Memory Clinics. J Alzheimers Dis. 2015;49(4):1075-83.
  2. Wawrziczny E, Pasquier F, Ducharme F, Kergoat MJ, Antoine P. From ‘needing to know’ to ‘needing not to know more’: an interpretative phenomenological analysis of couples’ experiences with early-onset Alzheimer’s disease.Scand J Caring Sci. 2015 Oct 9. doi: 10.1111/scs.12290. [Epub ahead of print]
  3. Caroppo P, Habert MO, Durrleman S, Funkiewiez A, Perlbarg V, Hahn V, Bertin H, Gaubert M, Routier A, Hannequin D, Deramecourt V, Pasquier F, Rivaud-Pechoux S, Vercelletto M, Edouart G, Valabregue R, Lejeune P, Didic M, Corvol JC, Benali H, Lehericy S, Dubois B, Colliot O, Brice A, Le Ber I; Predict-PGRN study group. Lateral Temporal Lobe: An Early Imaging Marker of the Presymptomatic GRN Disease? J Alzheimers Dis. 2015;47(3):751-9.
  4. Rovelet-Lecrux A, Charbonnier C, Wallon D, Nicolas G, Seaman MN, Pottier C, Breusegem SY, Mathur PP, Jenardhanan P, Le Guennec K, Mukadam AS, Quenez O, Coutant S, Rousseau S, Richard AC, Boland A, Deleuze JF, Frebourg T, Hannequin D, Campion D; CNR-MAJ collaborators. De novo deleterious genetic variations target a biological network centered on Aβ peptide in early-onset Alzheimer disease. Mol Psychiatry. 2015 Sep;20(9):1046-56.
  5. Le Rhun E, Delbeuck X, Lefeuvre-Plesse C, Kramar A, Skrobala E, Pasquier F, Bonneterre J. A phase III randomized multicenter trial evaluating cognition in post-menopausal breast cancer patients receiving adjuvant hormonotherapy. Breast Cancer Res Treat. 2015 Aug;152(3):569-80
  6. Dumurgier J, Schraen S, Gabelle A, Vercruysse O, Bombois S, Laplanche JL, Peoc’h K, Sablonnière B, Kastanenka KV, Delaby C, Pasquier F, Touchon J, Hugon J, Paquet C, Lehmann S. Cerebrospinal fluid amyloid-β 42/40 ratio in clinical setting of memory centers: a multicentric study. Alzheimers Res Ther. 2015 Jun 1;7(1):30.
  7. Verclytte S, Lopes R, Delmaire C, Ferre JC, Pasquier F, Leclerc X. Optimization of brain perfusion image quality by cortical surface-based projection of arterial spin labeling maps in early-onset Alzheimer’s disease patients. Eur Radiol. 2015 Aug;25(8):2479-84.

2014

  1. De Reuck J, Caparros-Lefebvre D, Deramecourt V, Defebvre L, Auger F, Durieux N, Bordet R, Pasquier F, Maurage CA. Prevalence of small cerebral bleeds in patients with progressive supranuclear palsy: a neuropathological study with 7.0-Tesla magnetic resonance imaging correlates. Folia Neuropathol. 2014;52(4):421-7.
  2. Ducharme F, Kergoat MJ, Coulombe R, Lévesque L, Antoine P, Pasquier F. Unmet support needs of early-onset dementia family caregivers: a mixed-design study. BMC Nurs. 2014 Dec 19;13(1):49.
  3. Lehmann S, Dumurgier J, Schraen S, Wallon D, Blanc F, Magnin E, Bombois S, Bousiges O, Campion D, Cretin B, Delaby C, Hannequin D, Jung B, Hugon J, Laplanche JL, Miguet-Alfonsi C, Peoc’h K, Philippi N, Quillard-Muraine M, Sablonnière B, Touchon J, Vercruysse O, Paquet C, Pasquier F, Gabelle A. A diagnostic scale for Alzheimer’s disease based on cerebrospinal fluid biomarker profiles. Alzheimers Res Ther. 2014 Jun 26;6(3):38.
  4. Ferrari R, (…) , Pasquier F, Rollin A, Deramecourt V, Lebert F, Kapogiannis D, Ferrucci L, Pickering-Brown S, Singleton AB, Hardy J, Momeni P. Frontotemporal dementia and its subtypes: a genome-wide association study. Lancet Neurol. 2014 Jul;13(7):686-99.
  5. Escott-Price V, (…), Pasquier F, (…) , Seshadri S, Schellenberg GD, Amouyel P, Williams J; Cardiovascular Health Study (CHS). Gene-wide analysis detects two new susceptibility genes for Alzheimer’s disease. PLoS One. 2014 Jun 12;9(6):
  6. Murao K, Leys D, Jacquin A, Kitazono T, Bordet R, Béjot Y, Kimura K, Godefroy O, Wakisaka Y, Moulin S, Ago T, Sibon I, Bombois S, Mas JL, Hénon H, Pasquier F, Giroud M, Cordonnier C, Okada Y; OPHELIE-COG investigators.Thrombolytic therapy for stroke in patients with preexisting cognitive impairment. Neurology. 2014 Jun 10;82(23):2048-54.
  7. De Reuck JL, Deramecourt V, Auger F, Durieux N, Cordonnier C, Devos D, Defebvre L, Moreau C, Caparros-Lefebvre D, Leys D, Maurage CA, Pasquier F, Bordet R. Iron deposits in post-mortem brains of patients with neurodegenerative and cerebrovascular diseases: a semi-quantitative 7.0 T magnetic resonance imaging study. Eur J Neurol. 2014 Jul;21(7):1026-31
  8. Troussière AC, Charley CM, Salleron J, Richard F, Delbeuck X, Derambure P, Pasquier F, Bombois S. Treatment of sleep apnoea syndrome decreases cognitive decline in patients with Alzheimer’s disease.J Neurol Neurosurg Psychiatry. 2014 Dec;85(12):1405-8.
  9. Sachdev P, Kalaria R, O’Brien J, Skoog I, Alladi S, Black SE, Blacker D, Blazer DG, Chen C, Chui H, Ganguli M, Jellinger K, Jeste DV, Pasquier F, Paulsen J, Prins N, Rockwood K, Roman G, Scheltens P; Internationlal Society for Vascular Behavioral and Cognitive Disorders. Diagnostic criteria for vascular cognitive disorders: a VASCOG statement.Alzheimer Dis Assoc Disord. 2014 Jul-Sep;28(3):206-18.
  10. Murao K, Bombois S, Cordonnier C, Hénon H, Bordet R, Pasquier F, Leys D. Influence of cognitive impairment on the management of ischaemic stroke. Rev Neurol (Paris). 2014 Mar;170(3):177-86
  11. Troussière AC, Wallon D, Mouton-Liger F, Yatimi R, Robert P, Hugon J, Hannequin D, Pasquier F, Paquet C. Who needs cerebrospinal biomarkers? A national survey in clinical practice. J Alzheimers Dis. 2014;40(4):857-61.
  12. Jacquin A, Deramecourt V, Bakchine S, Maurage CA, Pasquier F. Unusual features of Creutzfeldt-Jakob disease followed-up in a memory clinic. J Neurol. 2014 Apr;261(4):696-701.
  13. Clot F, Rovelet-Lecrux A, Lamari F, Noël S, Keren B, Camuzat A, Michon A, Jornea L, Laudier B, de Septenville A, Caroppo P, Campion D, Cazeneuve C, Brice A, LeGuern E, Le Ber I; French clinical and genetic research network on FTLD/FTLD-ALS. Partial deletions of the GRN gene are a cause of frontotemporal lobar degeneration.Neurogenetics. 2014 May;15(2):95-100.
  14. De Reuck J, Deramecourt V, Cordonnier C, Auger F, Durieux N, Pasquier F, Bordet R, Defebvre L, Caparros-Lefebvre D, Maurage CA, Leys D. Superficial siderosis of the central nervous system: a post-mortem 7.0-tesla magnetic resonance imaging study with neuropathological correlates. Cerebrovasc Dis. 2013;36(5-6):412-7.
  15. Lehmann S, Schraen S, Quadrio I, Paquet C, Bombois S, Delaby C, Dorey A, Dumurgier J, Hirtz C, Krolak-Salmon P, Laplanche JL, Moreaud O, Peoc’h K, Rouaud O, Sablonnière B, Thouvenot E, Touchon J, Vercruysse O, Hugon J, Gabelle A, Pasquier F, Perret-Liaudet A. Impact of harmonization of collection tubes on Alzheimer’s disease diagnosis. Alzheimers Dement. 2014 Oct;10(5 Suppl):S390-S394.e2.
  16. Mouton-Liger F, Wallon D, Troussière AC, Yatimi R, Dumurgier J, Magnin E, de la Sayette V, Duron E, Philippi N, Beaufils E, Gabelle A, Croisile B, Robert P, Pasquier F, Hannequin D, Hugon J, Paquet C. Impact of cerebro-spinal fluid biomarkers of Alzheimer’s disease in clinical practice: a multicentric study. J Neurol. 2014 Jan;261(1):144-51.
  17. Le Ber I, Van Bortel I, Nicolas G, Bouya-Ahmed K, Camuzat A, Wallon D, De Septenville A, Latouche M, Lattante S, Kabashi E, Jornea L, Hannequin D, Brice A; French research Network on FTLD/FTLD-ALS. hnRNPA2B1 and hnRNPA1 mutations are rare in patients with « multisystem proteinopathy » and frontotemporal lobar degeneration phenotypes. Neurobiol Aging. 2014 Apr;35(4):934.e5-6.

2012

Hébergement des personnes atteintes de maladies d’Alzheimer ou apparentées avant 60 ans, Médecine

Enquête en institution de l’accueil des malades jeunes, Revue hospitalière de France

2011

2010

Spécificités des « malades jeunes », réflexions cliniques et éthiques, Gériatrie & Psychologie & Neuropsychiatrie du vieillissement